Spain Blocks Access to Prediction Markets Kalshi and Polymarket Over Gambling Law Concerns Oura Files Confidentially for IPO Expanding Health Wearable Market Reach Jobless Claims Drop to Lowest Level in Over a Month Signaling Persistent Labor Market Strength UK Spy Chief Warns West Faces Moment of Consequence as Threats from Russia and China Intensify Bond Markets Signal Persistent Inflation Pressure Raising Stakes for US Policymakers Jim Cramer Advises Holding Astera Labs Shares Amid Market Uncertainty XBIO Q2 2025 Earnings EPS Beat on Lower Net Loss PreRevenue Status Maintains AON Q1 2026 Earnings EPS Surpasses Estimates by 029 CCCC Q1 2026 Earnings NarrowerThanExpected Loss Signals Cost Discipline Amid PreRevenue Phase Customers Bancorp CUBI Q1 2026 Earnings EPS Beat Highlights Profitability Resilience PNC Q1 2026 Earnings EPS Beat Amid Modest Stock Reaction Corsair Gaming Q1 2026 Earnings Strong EPS Beat Drives Stock Rally The Bancorp Inc TBBK Gains 125 as Shares Test Midpoint of Key Range Medicus Pharma Ltd MDCX Edges Higher Testing Key Resistance at 032 Merchants Bancorp Preferred Series C MBINN Edges Higher as Support Holds Senti Biosciences Edges Higher Near Key Resistance Level Genesis Energy GEL Slips 525 as Selling Pressure Tests Key Support Zone Alberta Separation Referendum Carney Highlights Provinces Essential Role in Canadian Economy UONEK Q1 2026 Earnings Reported Loss Amidst No Analyst Coverage Backblaze Inc BLZE Edges Higher in Quiet Trading Holding Above Key Support Levels Parsons Corporation PSN Q1 2026 Earnings EPS Surges Past Estimates as Operational Execution Drives Performance Amplitech Group Inc AMPGZ Q1 2026 Earnings EPS Miss and Steep Stock Decline Highlight Ongoing Challenges BWA Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Focus AGIO Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares LEA Q1 2026 Earnings Earnings Per Share Surpasses Estimates on Strong Operational Performance Energy Services of America Corporation ESOA Q1 2026 Earnings Profit Surges Past Expectations But Revenue Details Remain Unclear NVO Q1 2026 Earnings EPS Surges Past Estimates as Obesity Drug Sales Drive Margin Gains